Evidence map›Paper›PMID 21911607›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Raphael Schneider, Alma Nazlie Mohebiany, Igal Ifergan, Diane Beauseigle, Pierre Duquette, Alexandre Prat, Nathalie Arbour

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. PD-1Oncology research · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The IL-27/IL-27R axis is altered in CD4Clinical & translational immunology · 2021
    Article
  17. Article
  18. Biomedical optics express · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raphael SchneiderDépartement de Médecine, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec H2L 4M1, Canada.
Alma Nazlie Mohebiany
Igal Ifergan
Diane Beauseigle
Pierre Duquette
Alexandre Prat
Nathalie Arbour
Centre Hospitalier de l’Université de Montréal · CA

Funding

Integrating innate and adaptive immunity in cancer therapyR01CA100656 · NCI · UNIVERSITY OF LOUISVILLE · PI EGILMEZ, NEJAT K · 2004 to 2014
$2.9M
CIHR 79785-1NCI NIH HHS R01-CA100656
6 · The paper itself

Abstract

Multiple lines of evidence suggest that CD8 T cells contribute to the pathogenesis of multiple sclerosis (MS). However, the sources and involvement of cytokines such as IL-15 in activating these cells is still unresolved. To investigate the role of IL-15 in enhancing the activation of CD8 T cells in the context of MS, we determined cell types expressing the bioactive surface IL-15 in the peripheral blood of patients and evaluated the impact of this cytokine on CD8 T cell cytotoxicity and migration. Flow cytometric analysis showed a significantly greater proportion of B cells and monocytes from MS patients expressing IL-15 relative to controls. We established that CD40L activation of B cells from healthy donors increased their IL-15 levels, reaching those of MS patients. We also demonstrated an enhanced cytotoxic profile in CD8 T cells from MS patients upon stimulation with IL-15. Furthermore, we showed that IL-15 expressed by B cells and monocytes is sufficient and functional, enhancing granzyme B production by CD8 T cells upon coculture. Exposure of CD8 T cells to this cytokine enhanced their ability to kill glial cells as well as to migrate across an in vitro inflamed human blood-brain barrier. The elevated levels of IL-15 in patients relative to controls, the greater susceptibility of CD8 T cells from patients to IL-15, in addition to the enhanced cytotoxic responses by IL-15-exposed CD8 T cells, stresses the potential of therapeutic strategies to reduce peripheral sources of IL-15 in MS.

Indexed as

AdultB-LymphocytesCell SeparationChemotaxis, LeukocyteCoculture TechniquesFemaleFlow CytometryHumansInterleukin-15Lymphocyte ActivationMaleMiddle AgedMultiple SclerosisReverse Transcriptase Polymerase Chain ReactionT-Lymphocytes, CytotoxicInterleukin-15

Identifiers

PMID21911607
PMCPMC5052068
OpenAlexW2119361192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.